Simon Allen - 01 Feb 2022 Form 3 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role: Chief Executive Officer
Signature: /s/ James R. Merchant, as Attorney-in-Fact
Issuer symbol: ANEB
Transactions as of: 01 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 07 Feb 2022, 15:05:34 UTC
Next filing: 07 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney